Top Markets
#1 Islamic Coin Islamic Coin +154.32%
#2 PulseChain PulseChain +49.22%
#3 BOOK OF MEME BOOK OF MEME +26.04%
#4 Starpower Starpower +19.59%
#5 RedStone RedStone +16.92%
#6 Lighter Lighter +12.26%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.27%
#8 Monad Monad +10.36%
#9 SkyAI SkyAI +10.34%
#10 edgeX edgeX +10.32%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Level Biotechnology Inc. Level Biotechnology Inc.

Level Biotechnology Inc.

3118
Rank in Stocks #27462
Level Biotechnology Inc., founded in 1989 and based in New Taipei City, Taiwan,... Level Biotechnology Inc., founded in 1989 and based in New Taipei City, Taiwan, operates in the commercialization and distribution of scientific products and services. The company supplies specialized reagents and consumables for cell culture, immunology, and molecular biology, alongside advanced biomedical instrumentation, throughout Taiwan. Beyond product distribution, Level Biotechnology offers a comprehensive suite of research and testing services. These include expert assessments in mammalian and genetic toxicology, pharmacological studies, biocompatibility testing, and the production of model animals. The firm's preclinical research capabilities serve a diverse range of clients in the biotechnology, pharmaceutical, medical device, animal health, and agrichemical industries.
Share Price
$1.01
Market Cap
$32.71M
Change (1 day)
0.16%
Change (1 year)
-5.89%
Country
TW
Trade Level Biotechnology Inc. (3118)

Category

Healthcare
Number of shares outstanding for Level Biotechnology Inc. (3118)
Number of shares outstanding as of August 2026: 0
According to Level Biotechnology Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Level Biotechnology Inc. (3118) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH